Skip to main content
Clinical Trials/NCT00846079
NCT00846079
Unknown
Phase 3

Myocardial Perfusion Assessment With Multidetector Computed Tomography

Tennessee Heart and Vascular Institute, P.C.1 site in 1 country100 target enrollmentFebruary 2009

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
Tennessee Heart and Vascular Institute, P.C.
Enrollment
100
Locations
1
Primary Endpoint
Diagnostic Accuracy (Sensitivity/Specificity/Positive Predictive Value/Negative Predictive Value)
Last Updated
17 years ago

Overview

Brief Summary

Demonstrate the ability of muti-detector computed tomography to adequately perform stress testing will result in a veritable "one-stop shop" of non-invasive cardiac imaging that is, the ability to directly visualize heart arteries with high accuracy and to simultaniously determine the hemodynamic significance of any blockages visualized.

Registry
clinicaltrials.gov
Start Date
February 2009
End Date
September 2009
Last Updated
17 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Tennessee Heart and Vascular Institute, P.C.

Eligibility Criteria

Inclusion Criteria

  • Adults \>18 years of age
  • Adults undergoing myocardial perfusion SPECT imaging
  • Adults with suspected coronary artery disease

Exclusion Criteria

  • Known or suspected renal insufficiency (Creatinine \<1.7 mg/dl)
  • Allergy to contrast
  • Inability or contraindication to lexiscan or beta blocker

Outcomes

Primary Outcomes

Diagnostic Accuracy (Sensitivity/Specificity/Positive Predictive Value/Negative Predictive Value)

Time Frame: 6 months

Secondary Outcomes

  • Radiation dosimetry(6 months)

Study Sites (1)

Loading locations...

Similar Trials